Published in J Clin Invest on April 15, 1998
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med (2001) 5.74
Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest (1999) 1.85
The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A (2001) 1.61
Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol (2010) 1.23
Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. J Clin Invest (1998) 1.21
Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci U S A (1999) 1.13
Oxidative stress regulates adipocyte apolipoprotein e and suppresses its expression in obesity. Diabetes (2008) 1.01
Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J Leukoc Biol (2002) 1.00
ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium. Arterioscler Thromb Vasc Biol (2011) 0.98
LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. J Clin Invest (2001) 0.95
Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arterioscler Thromb Vasc Biol (2008) 0.90
LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. PLoS One (2015) 0.88
Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway. PLoS One (2012) 0.85
ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res (2012) 0.82
Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile. Arterioscler Thromb Vasc Biol (2013) 0.80
The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. Biomed Res Int (2013) 0.79
HDL-ApoE content regulates the displacement of hepatic lipase from cell surface proteoglycans. Am J Pathol (2009) 0.78
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice. J Lipid Res (2014) 0.78
Diet-induced hypercholesterolemia alters liver glycosaminoglycans and associated-lipoprotein receptors in rats. J Physiol Biochem (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Efficient trace-labelling of proteins with iodine. Nature (1958) 23.16
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (1992) 11.83
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell (1992) 10.97
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta (1972) 9.02
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A (1993) 3.92
Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A (1989) 3.26
NHLBI funding policies. Enhancing stability, predictability, and cost control. Circulation (1994) 3.11
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science (1995) 3.10
Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest (1998) 3.06
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (1989) 2.75
Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc Natl Acad Sci U S A (1982) 2.43
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A (1997) 2.34
Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci U S A (1981) 2.30
RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J (1996) 2.02
The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A (1994) 1.97
Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science (1994) 1.95
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem (1993) 1.92
Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc Natl Acad Sci U S A (1995) 1.90
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest (1995) 1.72
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest (1991) 1.64
Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest (1990) 1.58
Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem (1990) 1.56
Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A (1995) 1.34
Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem (1994) 1.29
Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J Lipid Res (1990) 1.23
Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J Clin Invest (1993) 1.18
Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res (1994) 1.16
Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem (1991) 1.11
Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse. J Lipid Res (1997) 1.10
Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J Clin Invest (1991) 0.97
Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J Clin Invest (1994) 0.95
Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr J Med Sci (1996) 0.91
Chylomicron remnants: hepatic receptors and metabolism. Curr Opin Lipidol (1995) 0.89
Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J Lipid Res (1993) 0.89
Interaction of apo E-containing lipoproteins with the LDL receptor-related protein LRP. Am J Physiol (1997) 0.82
Current perspectives on statins. Circulation (2000) 3.83
Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem (1999) 3.72
Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J Biol Chem (2000) 3.11
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science (1995) 3.10
Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol (2001) 2.68
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest (1999) 2.54
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A (1997) 2.34
Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest (2000) 2.21
Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol (2000) 2.12
Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur Heart J (1998) 2.05
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1993) 1.80
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest (1999) 1.76
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1994) 1.69
A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem (1999) 1.68
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J Biol Chem (2000) 1.68
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Growth hormone and the heart. Endocr Rev (1994) 1.53
Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Arterioscler Thromb Vasc Biol (2001) 1.52
Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab (2000) 1.49
Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia (2008) 1.47
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Obesity and cardiac function. Circulation (1981) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (1999) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation (2001) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int (2001) 1.32
Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem (1994) 1.29
Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem (1994) 1.27
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis (2009) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem (1994) 1.12
Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol (2001) 1.11
Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse. J Lipid Res (1997) 1.10
Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension. Arzneimittelforschung (1985) 1.10
A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J Biol Chem (1999) 1.10
Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab (1993) 1.09
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab (1993) 1.07
Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol (1999) 1.06
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J Biol Chem (1992) 1.04
Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation (1999) 1.04
Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. Atherosclerosis (1986) 1.04
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1996) 1.02
Low vitamin C and increased oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2. Free Radic Biol Med (2010) 1.00
Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. Nutr Metab Cardiovasc Dis (2010) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
A recycling pathway for resecretion of internalized apolipoprotein E in liver cells. J Biol Chem (2001) 0.99
Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance. J Lipid Res (1999) 0.98
Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men's Health Study. Nutr Metab Cardiovasc Dis (2011) 0.98
Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies. Curr Opin Lipidol (1999) 0.98
Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect. Schizophr Res (1997) 0.93
Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J Biol Chem (2001) 0.91
A psychosocial model of dementia care: theoretical and empirical support. Arch Psychiatr Nurs (1997) 0.91
Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab (1997) 0.90
Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin. Am J Dermatopathol (1996) 0.88
Evaluation of macrophage-specific promoters using lentiviral delivery in mice. Gene Ther (2011) 0.87
Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol (1994) 0.87
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Aspects of psychiatric admissions of migrants to hospitals in Perth, Western Australia. Aust N Z J Psychiatry (1997) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency. Eur J Endocrinol (1995) 0.84
Search for dilepton resonances in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2011) 0.83
Observation of a new χ(b) state in radiative transitions to Υ(1S) and Υ(2S) at ATLAS. Phys Rev Lett (2012) 0.82
Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. Arterioscler Thromb (1991) 0.82
Cardiac instrument development in a low-literacy population: the revised Chest Discomfort Diary. Heart Lung (2001) 0.82
[Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function]. Cardiologia (1999) 0.82
Search for new phenomena in tt events with large missing transverse momentum in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.82
Atherosclerotic lesions of apolipoprotein E deficient mice contain cells expressing S100 protein. Atherosclerosis (1999) 0.82
Search for scalar bottom quark pair production with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.82
Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice. Circulation (2001) 0.82
Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study. J Endocrinol Invest (2002) 0.82
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
Search for production of resonant states in the photon-jet mass distribution using pp collisions at √s=7 TeV collected by the ATLAS detector. Phys Rev Lett (2012) 0.81
Search for diphoton events with large missing transverse energy in 7 TeV proton-proton collisions with the ATLAS detector. Phys Rev Lett (2011) 0.81
Recycling of apolipoprotein E in mouse liver. J Biol Chem (1999) 0.81
Cardiac performance: growth hormone enters the race. Nat Med (1996) 0.80
Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk. Curr Atheroscler Rep (2000) 0.80
Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. Eur J Endocrinol (2004) 0.80
ApoA-IV is secreted on discrete HDL particles by the rat hepatoma cell line McA-RH7777 transfected with ApoA-IV cDNA. Arterioscler Thromb (1993) 0.79
[Distribution of myosin in a primary culture of human aortic intimal cells]. Biull Eksp Biol Med (1984) 0.79
Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice. Exp Neurol (1999) 0.79
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. J Clin Endocrinol Metab (1993) 0.79
Primitive hepatic hilum neoplasm. J Surg Oncol Suppl (1993) 0.79
Cell death in atheromatous plaque of the carotid artery occurs through necrosis rather than apoptosis. In Vivo (1998) 0.78
Search for the Higgs boson in the H→WW(*)→ℓ(+)νℓ(-)ν decay channel in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.78
Accumulation of human apolipoprotein-E in rat plasma after in vivo intramuscular injection of naked DNA. Biochem Biophys Res Commun (1994) 0.78
Ultrastructural identification of cells with dendritic cell appearance in atherosclerotic aorta of apolipoprotein E deficient mice. J Submicrosc Cytol Pathol (1999) 0.78
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. Cancer (1989) 0.78
Search for direct top squark pair production in final states with one isolated lepton, jets, and missing transverse momentum in sqrt[s] = 7 TeV pp collisions using 4.7 fb(-10 of ATLAS data. Phys Rev Lett (2012) 0.77
Identification of a filamin-like protein in chicken heart muscle. FEBS Lett (1981) 0.77